•This effect may potentially contribute to altered susceptibility to COVID-19 in COPD either beneficially (reduced viral entry) or detrimentally (removal of protective effect of ACE2 against hyperinflammation). The gene discussed is ACE2; the disease is chronic obstructive pulmonary disease.